Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England

References

1. Kavanagh D, Raman S, Sheerin NS. Management of hemolytic uremic syndrome. F1000Prime Rep 6:119 [View Article]
   [Google Scholar]
2. Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003; 290:1360–1370 [View Article][PubMed]
   [Google Scholar]
3. Rosales A, Hofer J, Zimmerhackl L-B, Jungraithmayr TC, Riedl M et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 2012; 54:1413–1421 [View Article][PubMed]
   [Google Scholar]
4. Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med 2009; 360:544–546 [View Article][PubMed]
   [Google Scholar]
5. McNamara LA, Topaz N, Wang X, Hariri S, Fox L et al. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep 2017; 66:734–737 [View Article][PubMed]
   [Google Scholar]
6. Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009; 2019:CD003595
   [Google Scholar]
7. Ardissino G, Tel F, Possenti I, Testa S, Consonni D et al. Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics 2016; 137:e20152153 [View Article][PubMed]
   [Google Scholar]
8. Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. J Med Microbiol 2014; 63:1181–1188 [View Article][PubMed]
   [Google Scholar]
9. Gentle A, Day MR, Hopkins KL, Godbole G, Jenkins C. Antimicrobial resistance in Shiga toxin-producing Escherichia coli other than serotype O157 : H7 in England, 2014-2016. J Med Microbiol 2020; 69:379–386 [View Article][PubMed]
   [Google Scholar]
10. EFSA BIOHAZ Panel Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bover-Cid S et al. Pathogenicity assessment of Shiga toxin-producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC. EFSA J 2020; 18:5967
    [Google Scholar]
11. Jenkins C, Lawson AJ, Cheasty T, Willshaw GA. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli . J Med Microbiol 2012; 61:1082–1085 [View Article][PubMed]
    [Google Scholar]
12. Jenkins C, Perry NT, Godbole G, Gharbia S. Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens. J Med Microbiol 2020; 69:487491 [View Article][PubMed]
    [Google Scholar]
13. McFarland N, Bundle N, Jenkins C, Godbole G, Mikhail A et al. Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015. Euro Surveill 2017; 22:30610 [View Article][PubMed]
    [Google Scholar]
14. Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect 2015; 143:3475–3487 [View Article][PubMed]
    [Google Scholar]
15. Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S et al. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying Shiga toxin-producing Escherichia coli . Arch Pediatr Adolesc Med 2012; 166:902–909 [View Article][PubMed]
    [Google Scholar]
16. Freedman SB, Xie J, Nettel-Aguirre A, Lee B, Chui L et al. Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study. Lancet Gastroenterol Hepatol 2017; 2:662–669 [View Article][PubMed]
    [Google Scholar]
17. McAuliffe G, Bissessor L, Williamson D, Moore S, Wilson J et al. Use of the EntericBio Gastro Panel II in a diagnostic microbiology laboratory: challenges and opportunities. Pathology 2017; 49:419–422 [View Article][PubMed]
    [Google Scholar]